|
Volumn 14, Issue 18, 2013, Pages 2611-2613
|
Comment on: Clinical benefits of ezetimibe: Absence of proof is just that
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EZETIMIBE;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
AORTA STENOSIS;
AORTA VALVE REPLACEMENT;
ARTERIAL WALL THICKNESS;
ATHEROSCLEROSIS;
CARDIOVASCULAR MORTALITY;
CLINICAL TRIAL (TOPIC);
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
HUMAN;
HYPERCHOLESTEROLEMIA;
LETTER;
MORBIDITY;
OUTCOME ASSESSMENT;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
HUMANS;
HYPERCHOLESTEROLEMIA;
SIMVASTATIN;
|
EID: 84887902711
PISSN: 14656566
EISSN: 17447666
Source Type: Journal
DOI: 10.1517/14656566.2013.849063 Document Type: Letter |
Times cited : (2)
|
References (6)
|